Microsoft 's (NASDAQ: MSFT) blowout quarter briefly propelled the stock across the $4 trillion threshold, allowing the tech ...

A compound growth rate of 19% from 2027 to 2035 gets you to $1 trillion in revenue. At 45% net margin and an earnings ...

Tyr Pharma's lead drug could transform treatment for pulmonary sarcoidosis, with phase 3 results due in Q3 2025 and analysts forecasting 400% upside. Zeta Global's AI marketing cloud is growing ...

OpenAI today launched GPT-5, its most sophisticated artificial intelligence model yet, delivering what chief executive Sam ...

Analysts warn of multi-phase price hikes and vendor reshuffling, forcing CIOs to prioritize US manufacturing and implement ...

Finally, there is NVIDIA. We don’t know how it’s doing. It reports on a different cycle, with its next report coming later ...

Nvidia remains the dominant AI chipmaker in the market, but where is the stock headed for the rest of this year and into the ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

There’s a good chance Nvidia won’t become the U.S. stock market’s first $5 trillion company. Now that Nvidia NVDA has topped ...

International and emerging market equities are outperforming US cap-weighted indices, signaling a rotation in market ...

Following the green light to ship chips to China, there appears to be no looking back for chip industry behemoth Nvidia (NVDA ...

The group, dubbed LLaMA (large language model Meta AI), is available via all the major cloud platforms and powers the Meta AI ...